Tizanidine
Product Images NDC 50090-2208

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-2208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

FDA Label Image

Tizanidine-2 (Tizanidine 2)

FDA Label Image

Tizanidine-3 (Tizanidine 3)

FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
This is data about the improvement of the Ashworth Score, a measure of spasticity, during a study. The mean dose used was 26.8mg and the data is analyzed at the end of titration (week 3), end of maintenance (week 7) and endpoint (last observation carried forward).*
FDA Label Image

Label Image (Lbl500902208)

Label Image (Lbl500902208)
Product No. 5580-0 is a package of 120 tablets with an unclear purpose. The text contains gibberish characters and incomplete information, making it difficult to provide a precise product description. The product may require further context to determine its use. Therefore, the product description is not available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.